Stool Banking for Fecal Microbiota Transplantation: Ready for Prime Time?

Overview

Journal Hepatobiliary Surg Nutr

Publisher AME Publishing Company

Date 2021 Feb 12

PMID 33575297

Citations 4

Authors

Srishti Saha

Sahil Khanna

Affiliations

Soon will be listed here.

Citing Articles

Modulating the microbiome in chronic liver diseases - current evidence on the role of fecal microbiota transplantation.

Saha S, Schnabl B Expert Rev Gastroenterol Hepatol. 2025; 19(1):53-64.

PMID: 39760535 PMC: 11882407. DOI: 10.1080/17474124.2025.2450707.

Past, present, and future of microbiome-based therapies.

Manrique P, Montero I, Fernandez-Gosende M, Martinez N, Cantabrana C, Rios-Covian D Microbiome Res Rep. 2024; 3(2):23.

PMID: 38841413 PMC: 11149097. DOI: 10.20517/mrr.2023.80.

Gut microbiome evolution impacts the clinical outcomes of diseases.

Sun L, Li J, Feng Y, Sun Y Hepatobiliary Surg Nutr. 2023; 12(2):261-263.

PMID: 37124679 PMC: 10129888. DOI: 10.21037/hbsn-23-127.

Insight into the gut microbiome dysbiosis in patients with liver failure after extended-hepatectomy.

Xie F, Bazhabayi M, Li B, Yuan Y Ann Transl Med. 2022; 10(21):1186.

PMID: 36467368 PMC: 9708476. DOI: 10.21037/atm-22-3278.

Using the microbiome in clinical practice.

Turjeman S, Koren O Microb Biotechnol. 2021; 15(1):129-134.

PMID: 34767683 PMC: 8719822. DOI: 10.1111/1751-7915.13971.

References

Paramsothy S, Borody T, Lin E, Finlayson S, Walsh A, Samuel D . Donor Recruitment for Fecal Microbiota Transplantation. Inflamm Bowel Dis. 2015; 21(7):1600-6. DOI: 10.1097/MIB.0000000000000405. View

Craven L, Parvathy S, Tat-Ko J, Burton J, Silverman M . Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases. Open Forum Infect Dis. 2017; 4(4):ofx243. PMC: 5730934. DOI: 10.1093/ofid/ofx243. View

McDonald L, Gerding D, Johnson S, Bakken J, Carroll K, Coffin S . Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018; 66(7):987-994. DOI: 10.1093/cid/ciy149. View

Cammarota G, Ianiro G, Kelly C, Mullish B, Allegretti J, Kassam Z . International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut. 2019; 68(12):2111-2121. PMC: 6872442. DOI: 10.1136/gutjnl-2019-319548. View

van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal E, de Vos W . Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013; 368(5):407-15. DOI: 10.1056/NEJMoa1205037. View

DeFilipp Z, Bloom P, Torres Soto M, Mansour M, Sater M, Huntley M . Drug-Resistant Bacteremia Transmitted by Fecal Microbiota Transplant. N Engl J Med. 2019; 381(21):2043-2050. DOI: 10.1056/NEJMoa1910437. View

Quraishi M, Segal J, Mullish B, McCune V, Hawkey P, Colville A . National survey of practice of faecal microbiota transplantation for Clostridium difficile infection in the UK. J Hosp Infect. 2016; 95(4):444-445. DOI: 10.1016/j.jhin.2016.10.023. View

Wilson B, Vatanen T, Cutfield W, OSullivan J . The Super-Donor Phenomenon in Fecal Microbiota Transplantation. Front Cell Infect Microbiol. 2019; 9:2. PMC: 6348388. DOI: 10.3389/fcimb.2019.00002. View

Joseph J, Saha S, Greenberg-Worisek A . Fecal Microbiota Transplantation: An Ambiguous Translational Pathway for a Promising Treatment. Clin Transl Sci. 2019; 12(3):206-208. PMC: 6510370. DOI: 10.1111/cts.12621. View

10.

Costello S, Tucker E, La Brooy J, Schoeman M, Andrews J . Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection. Clin Infect Dis. 2015; 62(7):908-14. DOI: 10.1093/cid/civ994. View

11.

Tariq R, Weatherly R, Kammer P, Pardi D, Khanna S . Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection. J Clin Gastroenterol. 2016; 52(2):146-150. DOI: 10.1097/MCG.0000000000000768. View